Expression of E-cadherin and α-catenin in T1 N0 laryngeal cancer

Anticancer Research

Volumn 32, Issue 12, 2012, Pages 5245-5249

  Carico, Elisabetta ^a   Radici, Marco ^b   Losito, Nunzia Simona ^c   Raffa, Salvatore ^a   Firrisi, Luca ^b   Fabiano, Alfredo ^b   Manola, Marco ^d   Vecchione, Aldo ^c   Giovagnoli, Maria Rosaria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c Giovanni Pascale National Institute for Research and Treatment of Tumours   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

A catenin; Adhesion molecules; E cadherin; Immunohistochemistry; Laryngeal cancer

Indexed keywords

ALPHA CATENIN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CARCINOMA IN SITU; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL BIOPSY; LARYNX CANCER; LARYNX MUCOSA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; ALPHA CATENIN; BIOPSY; CADHERINS; CARCINOMA IN SITU; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84872562157     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Le QT and Giaccia AJ: Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer. Clin Cancer Res 9: 4287-4295, 2003.
2. Saunders JR Jr: The genetic basis of head and neck carcinoma. Am J Surg 174: 459-461, 1997.
3. Liu M, Lawson G, Delos M, Jamart J, Chatelain B, Remacle M and Marbaix E: Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol 260: 28-34, 2003.
4. Takeichi M: Cadherins in cancer: implication for invasion and metastasis. Curr Opin Cell Biol 5: 806-811, 1993.
5. Hinck L, Nathke IS, Papkoff J and Nelson WJ: Dynamics of cadherin/catenin complex formation: Novel protein interactions and pathways of complex assembly. J Cell Biol 125: 1327-1340, 1994.
6. Aberle H, Schwartz H and Kemler R: Cadherin-catenin complex: Protein interactions and their implication for cadherin function. J Cell Biochem 61: 514-523, 1996.
7. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D and Birchmeier W: E-Cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
8. Van Aken E, De Wever O, Correia da Rocha AS and Mareel M: Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439: 725-751, 2001.
9. Serini G, Trusolino L, Maggiorato E, Cremona O, de Rossi M, Angeli A, Orlandi F and Marchisio PC: Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Natl Cancer Inst 88: 442-449, 1996.
10. Buongiorno PF, al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, Orringer MB and Beer DG: E-Cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 71: 166-172, 1995.
11. Siitonen SM, Kononen JTT, Helin HJ, Rantala IS, Holli KA and Isola JJ: Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402, 1996.
12. Sung-Chul L and Mi-Sook L: Significance of E-cadherin/β-catenin complex and cyclin D1 in breast cancer. Oncol Rep 9: 915-928, 2002.
13. Oka H, H Shiozaki H, Kobayashi K, Tahara H, Tamura S, Miyata M, Doki Y, Iihara K, Mattsuyoshi N and Hirano S: Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol 421: 149-156, 1992.
14. Weinel RJ, Neumann K, Kisker O and Rosendahl A: Expression and potential role of E-cadherin in pancreatic carcinoma. Int J Pancreatol 19: 25-30, 1996.
15. Wakatsuki S, Watanabe R, Saito K, Katagiri A, Sato S and Tomita Y: Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett 103: 11-17, 1996.
16. Cheng L, Nagabhushan M, Pretlow TP, Amini SB and Pretlow TG: Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 148: 1375-1380, 1996.
17. Carico E, Atlante M, Bucci B, Nofroni I and Vecchione A: E-cadherin and α-catenin expression during tumour progression of cervical epithelium. Gynecol Oncol 80: 156-161, 2001.
18. Carico E, Fulciniti F, Giovagnoli MR, Losito NS, Botti G, Benincasa G, Farnetano MG and Vecchione A: Adhesion molecules and p16 expression in endocervical adenocarcinoma. Virchows Arch 455: 245-251, 2009.
19. Carico E, Atlante M, Giarnieri E, Raffa S, Bucci B, Giovagnoli MR and Vecchione A: E-cadherin and α-catenin expression in normal, hyperplastic and neoplastic endometrium. Anticancer Res 30: 4993-4998, 2010.
20. Danen EH, TJ de Vries, R Morandini, GG Ghanem, DJ Ruiter and GN van Muijen: E-Cadherin expression in human melanoma. Melanoma Res 6: 127-131, 1996.
21. Tohma Y, Yamashima T and Yamashita J: Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human arachnoid villi and meningiomas. Cancer Res 52: 1981-1987, 1992.
22. Hirvikoski P, Virtaniemi J, Kumpulainen E and Kosma VM: Supraglottic and glottic carcinomas: clinically and biologically distinct entities? Eur J Cancer 38: 1717-1723, 2002.
23. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W: E-Cadherin expression in squamous cell carcinoma of head and neck: Inverse correlation with tumour dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
24. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F and Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11: 1873-1878, 1993.
25. Eriksen JG, Steiniche T and Overgaard J: The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Acta Oncologica 44: 50-58, 2005.
26. Sobin LH and Shanmugaratnam K: Histological Typing of Tumours of the Upper Respiratory Tract and Ear. Shanmugaratnam K. (ed.). Berlin, Springer-Verlag, pp. 26-27, 1991.
27. Rodrigo JP, Dominguez F, Alvarez C, Manrique C, Herrero A and Suarez C: Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38: 1059-1064, 2002.
28. Mattijssen V, Peters HM, Schalkwijk L, Manni JJ, van't Hof-Grootenboer B, de Mulder PH and Ruiter DJ: E-cadherin expression in head and neck squamous - cell carcinoma is associated with clinical outcome: Int J Cancer 55: 580-585, 1993.
29. 2 for the diagnosis and treatment of glottic carcinoma (T1-selected T2). Tumori 89: 263-266, 2003.
30. Rodrigo JP, Cabanillas R, Franco V and Suarez C: Efficacy of routine bilateral neck dissection in the management of the N0 neck in T1-T2 unilateral supraglottic cancer. Head Neck 28: 534-539, 2006.